Post-COVID-19 Guillain-Barré Syndrome: A case report from Oman

Authors

• Mohammed M. Al-Zadjali, Department of Psychiatry, Oman Medical Specialty Board, Muscat, Oman
• Emaad Al Shibli, Department of Medicine, Sultan Qaboos University Hospital, Muscat, Oman
• Mohammed Al Maskari, Department of Medicine, Sultan Qaboos University Hospital, Muscat, Oman
• Arunodaya R. Gujjar, Department of Neurology, Sultan Qaboos University Hospital, Muscat, Oman
• Abdullah Al Asmi, Department of Neurology, Sultan Qaboos University Hospital, Muscat, Oman

Abstract

Guillain-Barré syndrome (GBS) has been reported as one of the neurological manifestations linked to COVID-19, a severe acute respiratory syndrome caused by coronavirus 2. We present the case of a 72-year-old male patient attending a tertiary care hospital in Muscat, Oman, in 2020 with a history of progressive bilateral limb weakness and numbness. The current diagnosis was in line with a rare complication of COVID-19. After exclusion of other possible causes, a diagnosis of GBS induced by COVID-19 was made. The patient received 0.4g/kg of intravenous immunoglobulin (IVIG) per day for five days. This case report highlights the characteristics and course of GBS following COVID-19 infection. Further studies are needed to characterize the manifestations and course of various neuromuscular disorders in relation to COVID-19 infection.

Article Type

Case Report

Publication Date

8-25-2022

First Page

409

Last Page

412

Creative Commons License

This work is licensed under a Creative Commons Attribution-No Derivative Works 4.0 International License.

Recommended Citation

Al-Zadjali, Mohammed M.; Al Shibli, Emaad; Al Maskari, Mohammed; Gujjar, Arunodaya R.; and Al Asmi, Abdullah (2022) "Post-COVID-19 Guillain-Barré Syndrome: A case report from Oman," Sultan Qaboos University Medical Journal: Vol. 22: 409-412.
DOI: https://doi.org/10.18295/squmj.6.2021.090